{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:48:54Z","timestamp":1788871734552,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Spanish Ministry of Economy and Competitiveness","award":["RD06\/0010\/0013"],"award-info":[{"award-number":["RD06\/0010\/0013"]}]},{"name":"Spanish Ministry of Health"},{"name":"Galician Government"},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.neurobiolaging.2014.01.017","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T12:20:13Z","timestamp":1389961213000},"page":"1726-1738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Aging-related dysregulation of dopamine and angiotensin receptor interaction"],"prefix":"10.1016","volume":"35","author":[{"given":"Bego\u00f1a","family":"Villar-Cheda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Dominguez-Meijide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Moratalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Labandeira-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.nbd.2011.11.005","article-title":"Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine","volume":"45","author":"Ares-Santos","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2003.12.001","article-title":"NADPH oxidase","volume":"16","author":"Babior","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.regpep.2004.12.027","article-title":"Protective effect of the inhibition of the renin-angiotensin system on aging","volume":"128","author":"Basso","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI36703","article-title":"Disruption of the Ang II type 1 receptor promotes longevity in mice","volume":"119","author":"Benigni","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11357-012-9408-8","article-title":"Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity","volume":"35","author":"Benigni","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib7","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.neurobiolaging.2008.09.010","article-title":"Aging enhances the neuroinflammatory response and alpha-synuclein nitration in rats","volume":"31","author":"Choi","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/HYPERTENSIONAHA.112.192302","article-title":"Altered functioning of both renal dopamine D1 and angiotensin II type 1 receptors causes hypertension in old rats","volume":"59","author":"Chugh","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib9","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00441.2012","article-title":"Renal dopamine and angiotensin II receptor signaling in age-related hypertension","volume":"304","author":"Chugh","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib10","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1111\/j.1460-9568.2006.05143.x","article-title":"Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease","volume":"24","author":"Colebrooke","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nbd.2006.11.013","article-title":"Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism","volume":"26","author":"Collier","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.neurobiolaging.2007.09.009","article-title":"Aging effects on the dopamine transporter expression and compensatory mechanisms","volume":"30","author":"Cruz-Muros","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1096\/fj.02-1049fje","article-title":"Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries","volume":"17","author":"Csiszar","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ab.2007.06.045","article-title":"Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS\/MS: metabolism by bovine adrenal endothelial cells","volume":"369","author":"Cui","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.parkreldis.2011.11.025","article-title":"The aging striatal dopamine function","volume":"18","author":"Darbin","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","article-title":"Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation","volume":"66","author":"Darmopil","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.22284","article-title":"Age-specific progression of nigrostriatal dysfunction in Parkinson's disease","volume":"69","author":"de la Fuente-Fern\u00e1ndez","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mcn.2005.01.003","article-title":"Dopamine and noradrenaline control distinct functions in rodent microglial cells","volume":"29","author":"F\u00e4rber","year":"2005","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib19","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF03160175","article-title":"Dopamine receptors status after unilateral nigral 6-OHDA lesion. Autoradiographic and in situ hybridization study in the rat brain","volume":"19","author":"Fornaretto","year":"1993","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2008.11.003","article-title":"NADPH oxidases and angiotensin II receptor signaling","volume":"302","author":"Garrido","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00429-012-0402-9","article-title":"Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra","volume":"218","author":"Garrido-Gil","year":"2013","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MNH.0b013e32831a9e0b","article-title":"Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance","volume":"18","author":"Gildea","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-2-1","article-title":"Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra","volume":"2","author":"Grammatopoulos","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nbd.2011.01.033","article-title":"Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA","volume":"42","author":"Granado","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NADPH oxidase. Role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nbd.2007.01.004","article-title":"Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid \u03b2-protein metabolism in mouse models of Alzheimer disease","volume":"26","author":"Hemming","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90576-9","article-title":"Correlation of apomorphine and amphetamine\u2013induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats","volume":"626","author":"Hudson","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pbb.2011.05.007","article-title":"Aged monkeys as a partial model for Parkinson's disease","volume":"99","author":"Hurley","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/01.HYP.32.6.1054","article-title":"Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules","volume":"32","author":"Hussain","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","article-title":"The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease","volume":"109","author":"Joglar","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib33","doi-asserted-by":"crossref","first-page":"F1110","DOI":"10.1152\/ajprenal.90336.2008","article-title":"Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells","volume":"295","author":"Khan","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1523\/JNEUROSCI.4287-10.2011","article-title":"Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice","volume":"31","author":"Kramer","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/brain\/123.2.366","article-title":"Preservation of midbrain catecholaminergic neurons in very old human subjects","volume":"123","author":"Kubis","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib36","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/HYPERTENSIONAHA.108.120642","article-title":"D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells","volume":"53","author":"Li","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jnr.20598","article-title":"Angiotensin-converting enzyme inhibition reduces oxidative stress and protect dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism","volume":"81","author":"Lopez-Real","year":"2005","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00004647-200405000-00008","article-title":"Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat","volume":"24","author":"Lou","year":"2004","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","article-title":"Role of the renin-angiotensin system in vascular inflammation","volume":"29","author":"Marchesi","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11906-012-0321-4","article-title":"Update on the angiotensin AT(2) receptor","volume":"15","author":"McCarthy","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410240415","article-title":"Rate of cell death in parkinsonism indicates active neuropathological process","volume":"24","author":"McGeer","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2004.09.014","article-title":"Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia","volume":"1029","author":"Miyazaki","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2006.03.004","article-title":"Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism","volume":"51","author":"Mu\u00f1oz","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.35.4.571","article-title":"Motor function in the normal aging population: treatment with levodopa","volume":"35","author":"Newman","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00004872-199917040-00012","article-title":"Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages","volume":"17","author":"Okamura","year":"1999","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00424-012-1146-3","article-title":"AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function","volume":"465","author":"Padia","year":"2013","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib47","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neurobiolaging.2006.02.018","article-title":"Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons","volume":"28","author":"Rey","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11357-011-9284-7","article-title":"Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease","volume":"34","author":"Rodriguez-Pallares","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1471-4159.2007.04699.x","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons","volume":"103","author":"Rodriguez-Pallares","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2008.03.003","article-title":"Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS","volume":"31","author":"Rodriguez-Pallares","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/brain\/awr320","article-title":"Different dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system","volume":"135","author":"Rodriguez-Perez","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","article-title":"Proinflammatory actions of angiotensin II","volume":"10","author":"Ruiz-Ortega","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11064-006-9232-6","article-title":"Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease","volume":"32","author":"Sanchez-Iglesias","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature11748","article-title":"Suppression of neuroinflammation by astrocytic dopamine D2 receptors via \u03b1B-crystallin","volume":"494","author":"Shao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib56","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.freeradbiomed.2007.02.019","article-title":"NADPH oxidase- and mitochondrion-derived superoxide at rostral ventrolateral medulla in endotoxin-induced cardiovascular depression","volume":"42","author":"Sheh","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib57","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bjp.0703566","article-title":"Differential role of angiotensin II receptor subtypes on endothelial superoxide formation","volume":"131","author":"Sohn","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib58","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1073\/pnas.0903602106","article-title":"Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system","volume":"106","author":"Stegbauer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/syn.1085","article-title":"Age-related changes of dopamine D1-like and D2-like receptor binding in the F344\/N rat striatum revealed by positron emission tomography and in\u00a0vitro receptor autoradiography","volume":"41","author":"Suzuki","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib60","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib61","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1523\/JNEUROSCI.16-23-07776.1996","article-title":"Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons","volume":"16","author":"Todd","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib62","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00059-004-2625-x","article-title":"Vascular inflammation in aging","volume":"29","author":"Ungvari","year":"2004","journal-title":"Herz"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib63","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/NEN.0b013e3181fa0308","article-title":"Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death","volume":"69","author":"Valenzuela","year":"2010","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib64","doi-asserted-by":"crossref","first-page":"204.e1","DOI":"10.1016\/j.neurobiolaging.2010.08.006","article-title":"Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration","volume":"33","author":"Villar-Cheda","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J","article-title":"Age-dependent decline of dopamine D1 receptors in human brain: a PET study","volume":"30","author":"Wang","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib66","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.HYP.33.1.335","article-title":"Angiotensin II type 1 receptor-mediated peroxide production in human macrophages","volume":"33","author":"Yanagitani","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib68","doi-asserted-by":"crossref","first-page":"F742","DOI":"10.1152\/ajprenal.00583.2011","article-title":"Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury","volume":"302","author":"Yang","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib69","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1152\/ajpregu.00434.2005","article-title":"D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure","volume":"290","author":"Yang","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(98)00110-3","article-title":"Age-related decline in striatal dopamine release and motoric function in brown Norway\/Fischer 344 hybrid rats","volume":"791","author":"Yurek","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1742-2094-8-129","article-title":"Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade","volume":"8","author":"Zawada","year":"2011","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib72","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.0000240500.96746.ec","article-title":"Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells","volume":"99","author":"Zeng","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib73","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.0000085334.34963.4E","article-title":"Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats","volume":"42","author":"Zeng","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cardiores.2007.07.014","article-title":"Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation","volume":"76","author":"Zhang","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.017_bib75","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2337\/db12-0046","article-title":"Intrarenal dopamine inhibits progression of diabetic nephropathy","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:22:34Z","timestamp":1759317754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0197458014000189"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.01.017","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aging-related dysregulation of dopamine and angiotensin receptor interaction","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}